ZipBio employs generative artificial intelligence to innovate in the field of therapeutic development. The company's technology focuses on creating new genes and proteins from scratch, aiming to address significant unmet medical needs. ZipBio's approach involves condensing multiple complex functions into compact therapeutic molecules, which are designed to be highly effective. This method of distilling biological complexity into more manageable forms represents the company's core product offering in the pharmaceutical and biotechnology sectors.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.